Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 to 45

Prenatal choline supplementation to support fetal brain development

Official title: A Randomized, Double-Blind, Placebo-controlled Clinical Trial of Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure on Growth and Cognitive Development: Pilot Arm for Non-Drinking Women

Run by Wayne State University · NCT07699393 · Data updated 2026-11-12

This study tests whether giving pregnant people choline can help their babies' brain development and growth, compared with a placebo, when alcohol exposure is not present.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment50 (estimated)
SponsorWayne State University
Academic / other
Locations1 site (Cape Town)
StatusRecruiting
StartedJuly 8, 2026
Main results expectedOctober 15, 2027
Study endsMay 15, 2028
Registry record updatedJuly 14, 2026
Trial IDNCT07699393 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women at ≤20 weeks gestation, abstinent from alcohol since conception, with low dietary choline intake and fluent in English or Afrikaans.

Probably not a fit

Individuals who continue alcohol exposure during pregnancy or have conditions that preclude choline supplementation may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind, placebo-controlled Phase 2 trial evaluates maternal choline supplementation during pregnancy in abstinent participants to see if it can support infant recognition memory, postnatal growth, eyeblink conditioning, and information processing speed. The protocol mirrors a prior pilot and uses choline bitartrate versus placebo, enrolling about 50 pregnant women and their infants. Primary outcomes include infant recognition memory and postnatal growth measures, with secondary outcomes spanning eyeblink conditioning, postnatal length, and processing speed. Eligible participants are adults 18+ with singleton pregnancies between ≤20 weeks gestation, who have abstained from alcohol since conception and have low dietary choline intake. Exclusion criteria include illicit drug use, HIV, certain medical conditions, or plans to relocate before study completion.

Why it matters

Potential benefit: If successful, maternal choline supplementation could improve early cognitive and growth outcomes in infants.

How similar studies have gone: Prior pilot data suggested improved eyeblink conditioning and catch-up growth with prenatal choline, supporting further testing in a larger, abstinent-cohort.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 yr
* ≤20 wk gestation
* Singleton pregnancy
* Abstinence from alcohol since conception (by report)
* Current choline dietary intake \<1 g/day
* Language fluency in English or Afrikaans

Exclusion Criteria:

* Use of methamphetamine or other illicit drugs other than marijuana during the past year
* HIV positive
* Pharmacologic treatment for a serious pre-existing medical condition (e.g., diabetes, hypertension, epilepsy, or cardiac problems)
* Having another child enrolled in the trial from a previous pregnancy
* Plans for mother or child to move away from the area prior to study completion

Where it's running

  • University of Cape Town
    Cape Town, South Africa
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.